Status:
COMPLETED
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to evaluate the safety and effectiveness of an investigational therapy for treating patients with open-angle glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- 18 years or older.
- Diagnosis of open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.
- Mean IOP in each eye less than 18 mmHg at the screening visit.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Pregnant.
- History of chronic or recurrent severe inflammatory eye disease.
- Ocular trauma within the past six months in either eye.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00293787
Start Date
June 1 2004
End Date
August 1 2005
Last Update
February 14 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.